[1] Steinbrink J, Leavens J, KauffmanCA, et al. Manifestations and outcomes of nocardia infections:Comparison of immunocompromised and nonimmunocompromised adult patients.Medicine (Baltimore) 2018 Oct;97(40):e12436.
[2] Mahajan KR. Disseminated nocardiosiswith cerebral and subcutaneous lesions on low-dose prednisone. Pract Neurol.2018Sep 21.
[3] Schlaberg R, Fisher MA, Hanson KE,et al. Susceptibility profiles of Nocardia isolates basedon current taxonomy. Antimicrob Agents Chemother.2014;58(2):795-800.
[4] Sylvia Valdezate, Noelia Garrido, GemaCarrasco,et al. Epidemiology and susceptibility to antimicrobial agents of themain Nocardia species in Spain .J Antimicrob Chemother 2017; 72: 754–761.